ARTHUR TZIANABOS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARTHUR TZIANABOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARTHUR TZIANABOS. ARTHUR TZIANABOS is Director in BIND Therapeutics, Inc ($BIND) and Chief Scientific Officer in OvaScience, Inc. ($OVAS) and President and CSO in OvaScience, Inc. ($OVAS) and Director in Stoke Therapeutics, Inc. ($STOK) and President & CEO in Homology Medicines, Inc. ($FIXX).
Latest Insider Trading Transactions of ARTHUR TZIANABOS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BIND, FIXX, OVAS, STOK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | M | 2.19 | 10,000 | 21,900 | 13,447 | |
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Sell | S | 60.67 | 10,000 | 606,652 | 0 | 10 K to 0 (-100.00 %) |
| Feb 23 2021 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Buy | M | 2.19 | 10,000 | 21,900 | 10,000 | 0 to 10 K |
| Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 13.78 | 254,000 | 3,500,120 | 254,000 | |
| Jun 05 2020 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 26.53 | 14,777 | 392,034 | 14,777 | |
| Feb 05 2020 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.16 | 12,500 | 202,021 | 77,505 | 90 K to 77.5 K (-13.89 %) |
| Jan 03 2020 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 20.50 | 12,500 | 256,191 | 90,005 | 102.5 K to 90 K (-12.19 %) |
| Dec 13 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 19.92 | 358,000 | 7,131,360 | 358,000 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.25 | 12,500 | 203,176 | 102,505 | 115 K to 102.5 K (-10.87 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.04 | 12,500 | 200,559 | 115,005 | 127.5 K to 115 K (-9.80 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.23 | 100 | 1,823 | 127,505 | 127.6 K to 127.5 K (-0.08 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 17.39 | 12,400 | 215,645 | 127,605 | 140 K to 127.6 K (-8.86 %) |
| Sep 12 2019 | STOK | Stoke Therapeutics ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 28.80 | 14,777 | 425,578 | 14,777 | |
| Sep 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.75 | 12,500 | 234,320 | 140,005 | 152.5 K to 140 K (-8.20 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.75 | 12,500 | 234,320 | 140,005 | 152.5 K to 140 K (-8.20 %) |
| Aug 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 17.37 | 12,500 | 217,111 | 152,505 | 165 K to 152.5 K (-7.58 %) |
| Jun 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 19.86 | 12,500 | 248,263 | 177,505 | 190 K to 177.5 K (-6.58 %) |
| Dec 18 2018 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 24.28 | 203,000 | 4,928,840 | 203,000 | |
| Mar 29 2018 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 16.00 | 92,376 | 1,478,016 | 92,376 | |
| Aug 30 2016 | BIND | DNIB UNWIND, INC. | TZIANABOS ARTHUR | Director | Option Exercise | M | 0.44 | 15,000 | 6,600 | 0 | |
| Aug 30 2016 | BIND | DNIB UNWIND, INC. | TZIANABOS ARTHUR | Director | Buy | M | 0.44 | 15,000 | 6,600 | 15,000 | 0 to 15 K |
| Jun 22 2016 | BIND | BIND Therapeutics, ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 0.44 | 15,000 | 6,600 | 15,000 | |
| Dec 07 2015 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | President and CSO | Grant | A | 0.00 | 25,000 | 0 | 25,400 | 400 to 25.4 K (+6,250.00 %) |
| Oct 14 2015 | BIND | BIND Therapeutics, ... | TZIANABOS ARTHUR | Director | Option Exercise | A | 4.52 | 25,000 | 113,000 | 25,000 | |
| Apr 09 2015 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | President and CSO | Buy | P | 28.77 | 225 | 6,473 | 400 | 175 to 400 (+128.57 %) |
| Apr 08 2015 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | President and CSO | Buy | P | 28.04 | 175 | 4,907 | 175 | 0 to 175 |
| Dec 06 2013 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | Chief Scientific Of ... | Option Exercise | A | 8.58 | 165,000 | 1,415,700 | 165,000 | |
| Sep 12 2013 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | Chief Scientific Of ... | Buy | P | 10.32 | 1,000 | 10,320 | 1,000 | 0 to 1,000 |
| Sep 12 2013 | OVAS | OvaScience, Inc. | TZIANABOS ARTHUR | Chief Scientific Of ... | Option Exercise | A | 14.27 | 312,000 | 4,452,240 | 312,000 |
Page: 1